Logo

Novartis Announces Spin-Off of Alcon Eye Care Business on April 9- 2019

Share this

M&A

Novartis Announces Spin-Off of Alcon Eye Care Business on April 9- 2019

Shots:

  • Novartis plans spin-off of its eye care business with an expected 100% spin-off on Apr 9- 2019 and has secured debt financing of $3.5B through banks
  • Novartis stockholder to receive Alcon share for every 5 Novartis shares/ADRs prior to the closing of trade on Apr 8- 2019 and will be listed on SIX and the NYSE under the ticker ALC
  • In 2011- Novartis acquired Alcon stake from Nestle for $39B to expand its ophthalmology portfolio. Novartis initially acquired only 25% of Alcon’s share for $11B and later acquired remaining shares for $28B

Click here to read full press release/ article | Ref: Exscientia | Image: Endpoints News


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions